aTyr Pharma
ATYR
aTyr Pharma (ATYR) earnings history
Most recent quarter
- Fiscal period
- Q2 2025
- Period end
- Jun 30, 2025
- EPS actual
- −$0.22
- EPS estimate
- −$0.18
- EPS surprise
- −19.24%
- Revenue surprise
- +0.00%
- Revenue
- $0.00
- Revenue estimate
- $0.00
- Reported
- Aug 7, 2025
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2025 | Aug 7, 2025 | −$0.18 | −$0.22 | −19.24% | $0.00 | SEC |
| Q1 2025 | May 7, 2025 | −$0.19 | −$0.17 | +10.99% | $0.00 | SEC |
| Q4 2024 | Mar 13, 2025 | −$0.23 | −$0.18 | +20.21% | $0.00 | SEC |
| Q3 2024 | Nov 7, 2024 | −$0.22 | −$0.23 | −4.55% | $0.00 | SEC |
| Q2 2024 | Aug 13, 2024 | −$0.25 | −$0.23 | +9.20% | $0.00 | SEC |
| Q1 2024 | May 2, 2024 | −$0.25 | −$0.23 | +8.00% | $235,000.00 | SEC |
| Q4 2023 | Mar 14, 2024 | −$0.24 | −$0.25 | −5.04% | $0.00 | SEC |
| Q3 2023 | Nov 9, 2023 | −$0.23 | −$0.20 | +11.50% | $353,000.00 | SEC |
| Q2 2023 | Aug 9, 2023 | −$0.28 | −$0.22 | +21.03% | $0.00 | SEC |
| Q1 2023 | May 9, 2023 | −$0.35 | −$0.29 | +17.14% | $0.00 | SEC |
| Q4 2022 | Mar 9, 2023 | −$0.48 | −$0.26 | +45.83% | $10.4M | SEC |
| Q3 2022 | Nov 10, 2022 | −$0.46 | −$0.46 | +0.71% | $0.00 | SEC |
| Q2 2022 | Aug 15, 2022 | −$0.38 | −$0.44 | −15.18% | $0.00 | SEC |
| Q1 2022 | May 9, 2022 | −$0.32 | −$0.44 | −39.24% | $0.00 | SEC |
| Q4 2021 | Mar 14, 2022 | −$0.28 | −$0.31 | −9.42% | $0.00 | SEC |
| Q3 2021 | Nov 12, 2021 | −$0.59 | −$0.42 | +29.16% | $0.00 | — |
| Q2 2021 | Aug 11, 2021 | −$0.51 | −$0.64 | −25.98% | $0.00 | — |
| Q1 2021 | May 13, 2021 | −$0.32 | −$0.51 | −60.63% | $0.00 | SEC |
| Q4 2020 | Mar 23, 2021 | −$0.82 | −$0.47 | +42.91% | $2.1M | SEC |
| Q3 2020 | Nov 12, 2020 | −$0.74 | −$0.68 | +8.52% | $148,000.00 | SEC |
Quarterly revenue
Frequently asked questions
When did aTyr Pharma (ATYR) last report earnings?
aTyr Pharma last reported on Aug 7, 2025, covering fiscal Q2 2025.
Did ATYR beat earnings estimates?
No. aTyr Pharma reported EPS of −$0.22 for Q2 2025 against a −$0.18 estimate — a 19.24% miss.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.